欢迎来到天天文库
浏览记录
ID:5347683
大小:1.25 MB
页数:4页
时间:2017-12-08
《香菇多糖联合化疗腔内注射治疗恶性胸腔积液的meta分析》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、第8卷第17期·总第97期◎D硼(K2,~TtOl2O10年09月E半月刊香菇多糖联合化疗腔内注射治疗恶性胸腔积液的Meta分析田鑫王伟钢贾立群1中日友好医院国际医疗部(100029).2中日友好医院肿瘤科(100029)摘要:目的系统评价香始多糖联合肿瘤化疗药物胸腔内灌注对恶性胸腔积液患者的临床疗效、生活质量、毒副反戍的影响。方法检索Pubmed、中文生物医学文献数据库、中文科技期刊数据库等数据库,同时手检相关文献,以随机对照试验为研究对象,采用RevMan5.0软件进行Meta分析,采用优势比作为效应合并指标。结果至2010年2月,共纳入18个研究1098例患者,香菇多糖联合化疗药物56
2、5例,单纯使用化疗药物533例。Meta分析显示香菇多糖联合化疗药方案比单纯化疗治疗恶性胸腔积液近期有效率更高(OR=3.48,95%CI2.64~4.59,P3、胸腔积液;香菇多糖;随机对照试验;Meta分析doi:10.39690.issn16722779.2010.17.14l文章编号:1672—2779(2010).17-0203—04Meta·AnalysisofIntrapleuralInjectionLentinancombinedandChemotherapyfor.Malignantpleuralefusion./anXin,WangWeigan8.,证Liqun(China-JapanFr~ndshipHospitagBajing100029)Abstract=ObjectiveToevaluatetheeffect,QOLanda4、dversereactionofintrapleuralinjectionLentinanandCisplatininthetreatmentmalignantpleuraleffusion.MethodsWesearchedalltherandomizedcontrolledtrials(RCTs)formPubmed,ChineseBiomedicalDatabase(CMB)bykeywords,Wealsohand—searchedrelevantjoumals.Mate—analysiswasconductedcombiningtheoddratiosoftheindividual5、studies.RevMan5.0.230wasusedintheanalysis.Tesults18RCTsincluding1098patieneswereincludedforefficacyanalysis.ItwasfoundthattheeficacyrateinLentinancombinedandCisplatingroupwassignificantlyhigherthanthatincontrolgroup(OR=348.95%CI264—4.59.P<1】.05).10RCTsshowedthatLentinancombinedandCisplatingrouphads6、ignificanteficacycomparedwithsimplecontrolgroupinqualityoflife(OR=3.27,95%CI2.24_4.78,P<13.05).15RCTswereincludedforsafetyanalysis,itwasfoundthattheratesofgastrointestinalupsetandhypodynamiainLentinancombinedandCisplatingroupweresignificantlylowerthanthoseincontrolgroup(P<13.05).ConclusionIntrapleu7、ralinjectionLentinancombinedandCisplatinmightbebeneficialintreatmentofmalignantpleuraleffusion,butitseficacyandsafetyneedtObeconfirmedwithhigh—qualityrandomizedcontrolledtrials.KeyWords:Malignantpleuraleffu
3、胸腔积液;香菇多糖;随机对照试验;Meta分析doi:10.39690.issn16722779.2010.17.14l文章编号:1672—2779(2010).17-0203—04Meta·AnalysisofIntrapleuralInjectionLentinancombinedandChemotherapyfor.Malignantpleuralefusion./anXin,WangWeigan8.,证Liqun(China-JapanFr~ndshipHospitagBajing100029)Abstract=ObjectiveToevaluatetheeffect,QOLanda
4、dversereactionofintrapleuralinjectionLentinanandCisplatininthetreatmentmalignantpleuraleffusion.MethodsWesearchedalltherandomizedcontrolledtrials(RCTs)formPubmed,ChineseBiomedicalDatabase(CMB)bykeywords,Wealsohand—searchedrelevantjoumals.Mate—analysiswasconductedcombiningtheoddratiosoftheindividual
5、studies.RevMan5.0.230wasusedintheanalysis.Tesults18RCTsincluding1098patieneswereincludedforefficacyanalysis.ItwasfoundthattheeficacyrateinLentinancombinedandCisplatingroupwassignificantlyhigherthanthatincontrolgroup(OR=348.95%CI264—4.59.P<1】.05).10RCTsshowedthatLentinancombinedandCisplatingrouphads
6、ignificanteficacycomparedwithsimplecontrolgroupinqualityoflife(OR=3.27,95%CI2.24_4.78,P<13.05).15RCTswereincludedforsafetyanalysis,itwasfoundthattheratesofgastrointestinalupsetandhypodynamiainLentinancombinedandCisplatingroupweresignificantlylowerthanthoseincontrolgroup(P<13.05).ConclusionIntrapleu
7、ralinjectionLentinancombinedandCisplatinmightbebeneficialintreatmentofmalignantpleuraleffusion,butitseficacyandsafetyneedtObeconfirmedwithhigh—qualityrandomizedcontrolledtrials.KeyWords:Malignantpleuraleffu
此文档下载收益归作者所有